Skip to Main Content

Paper Details

Acetylation-induced PCK isoenzyme transition promotes metabolic adaption of liver cancer to systemic therapy.
Cancer Letters
3
2021
-, KAT8, Lys, PCK isoenzyme, PCK1, PCK2, Sorafenib, advanced liver cancer, cytoplasmic PCK1, lenvatinib, liver cancer, lysine, lysine acetyltransferase 8, mitochondrial PCK2, patients, phosphoenolpyruvate, phosphoenolpyruvate carboxykinase isoform 2, resistant cells, sorafenib, sorafenib-resistant cells, tumor
Author NameAffiliation
Xiaohang ZhaoNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
  • 1 - 1

Datasets

Release 1.2